Validation of a Molecular Signature for Early Detection of Colorectal Cancer

NACompletedINTERVENTIONAL

Enrollment

3,421

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Colorectal Cancer ScreeningAdvanced Adenomas (AA)

Interventions

DIAGNOSTIC_TEST

blood sampling

Molecular signature using plasma sample

OTHER

stool sampling

Stool sampling (by the participant)

OTHER

colonoscopy

Colonoscopy will be performed in the course of a screening programme

Trial Locations (2)

MVZ für Gastroenterolgie am Bayerischen Platz, Berlin

Narodowy Instytut Onkologii w Warszawie Zakład Profilaktyki Nowotworów, Warsaw

All Listed Sponsors

collaborator

European Union H2020 SME Instrument

UNKNOWN

lead

ADVANCED MARKER DISCOVERY S.L.

INDUSTRY

NCT06738511 - Validation of a Molecular Signature for Early Detection of Colorectal Cancer | Biotech Hunter | Biotech Hunter